Johnson & Johnson Cash from Financing Quarterly:
-777.00M for March 31, 2013Johnson & Johnson Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -777.00M |
| Dec. 31, 2012 | -1.471B |
| Sept. 30, 2012 | -14.50B |
| June 30, 2012 | -3.403B |
| March 31, 2012 | -1.183B |
| Dec. 31, 2011 | -756.00M |
| Sept. 30, 2011 | -2.232B |
| June 30, 2011 | -639.00M |
| March 31, 2011 | -825.00M |
| Dec. 31, 2010 | 2.606B |
| Sept. 30, 2010 | -1.699B |
| June 30, 2010 | -2.065B |
| March 31, 2010 | -3.822B |
| Dec. 31, 2009 | 1.078B |
| Sept. 30, 2009 | -3.242B |
| June 30, 2009 | -2.06B |
| March 31, 2009 | 132.00M |
| Dec. 31, 2008 | -4.47B |
| Sept. 30, 2008 | -1.696B |
| June 30, 2008 | -188.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
JNJ Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Eli Lilly and Company | -1.730B |
| Pfizer | |
| Merck |
JNJ Cash from Financing Quarterly Rankings
| Overall |
44th percentile 4462 of 8005 |
| Sector |
20th percentile 548 of 686 in Healthcare |
| Industry |
34th percentile 36 of 55 in Drug Manufacturers - Major |
JNJ Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -14.50B | Sep 2012 |
| Maximum | 2.606B | Dec 2010 |
| Average | -2.061B |
